Cargando…
Core Patient-Reported Outcomes (PROs) and PRO Measures (PROMs) for Polypharmacy Medicines Reviews: A Sequential Mixed-Methods Study
PURPOSE: Problematic polypharmacy can exaggerate “medicine burden” for the patient. Patient-reported outcomes (PROs) are key indicators of medicine burden, and PRO measures (PROMs) can help patients articulate their perceptions of medicine burden. We aimed to: (a) evaluate what PROMs currently exist...
Autores principales: | Kotronoulas, Grigorios, Cooper, Mark, Johnston, Bridget |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916699/ https://www.ncbi.nlm.nih.gov/pubmed/31853173 http://dx.doi.org/10.2147/PPA.S236122 |
Ejemplares similares
-
Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs)
por: Weldring, Theresa, et al.
Publicado: (2013) -
Polypharmacy and Nutraceuticals in Veterans: Pros and Cons
por: Sciarra, Tommaso, et al.
Publicado: (2019) -
Patient‐reported outcomes (PROs) versus patient‐reported outcome measures (PROMs)—Is there a difference?
por: Jokstad, Asbjørn
Publicado: (2018) -
Correction: Development of a standard set of PROs and generic PROMs for Dutch medical specialist care
por: Voshaar, Martijn Oude, et al.
Publicado: (2023) -
A review of the barriers to using Patient‐Reported Outcomes (PROs) and Patient‐Reported Outcome Measures (PROMs) in routine cancer care
por: Nguyen, Hanh, et al.
Publicado: (2020)